WebA Phase 3b, Multicenter, Open-Label, Single-Arm Study to Evaluate the Safety, Tolerability, and Efficacy of Zilucoplan in Participants With Generalized Myasthenia Gravis Switching From Intravenous Complement Component 5 Inhibitors to … WebThis first-in-human study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324 in healthy male participants.#This was a randomised, double-blind, placebo-controlled ascending dosing study in two parts: in part 1, 30 participants received 0.004-11.475mgh-1of STR-324 or placebo (ratio 4:1) by 4h …
Efficacy and tolerability of an endogenous metabolic modulator …
WebSafety Versus Tolerability WebApr 6, 2024 · The presentation will cover clinical safety and tolerability data, alongside reinfection rates for the low dose (3 mg/mL) cohort at the 3-month follow-up highlighting the potent antimicrobial properties of Peptilogics’ engineered peptide PLG0206 for the treatment of periprosthetic joint infection (PJI), a life-threatening complication that patients may … baseball 2000
Safety, Tolerability and Immunogenicity of a Recombinant …
WebMethods. The safety, tolerability, and efficacy of cariprazine as an adjunctive treatment for patients with MDD with inadequate response to antidepressant alone was assessed in five placebo-controlled studies (two 6-week fixed-dose studies [NCT03738215; NCT03739203] and three 8-week flexible-dose studies [NCT00854100; NCT01715805; NCT01469377]) … WebIn addition to these studies, CORAL is currently setting up a therapeutic phase II clinical trial due to start in March 2024. This trial in partnership with BNITM, a German research institute, will assess the pharmacokinetics, safety and tolerability of the antiviral drug Favipiravir against the standard ribavirin treatment. WebApr 14, 2024 · A study to evaluate the safety and tolerability of the covalent phosphoinositide-3-kinase (PI3K)-alpha Inhibitor, TOS-358, in adult subjects with select solid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Clinical Trials and Late-Breaking Research); 2024 Apr 14-19; … baseball 2009